The vaccine advisory panel for the Food and Drug Administration (FDA) on Thursday voted to recommend matching the composition ...

A panel of independent experts that advises the Food and Drug Administration on vaccines has backed a proposal to use the ...

Dr. Kristin Moffitt, an infectious disease specialist at Boston Children's Hospital talks about concerns about COVID vaccines ...

The expert panel voted on Thursday to recommend replacing the primary Covid-19 vaccine series with the BA.4/5 bivalent shot.

The FDA hopes to simplify COVID-19 vaccine options to help cope with the continued presence and evolution of the virus.

Currently, Pfizer's and Moderna's omicron shots are authorized as a booster, while the first two doses are still the old shots based on the original strain.

A panel of the Food and Drug Administration's outside vaccine advisers voted unanimously Thursday in favor of "harmonizing" ...

In a document posted ahead of an advisory group meeting on Jan 26, the US Food and Drug Administration (FDA) today spelled ...

Protecting against Covid infection with the current mRNA technology is unrealistic, a vaccine expert said in a paper ...

The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet Thursday to discuss how to simplify ...

At a meeting of this FDA ... Covid-19 and who did not. It found that 1.9% of the study participants who received the original booster became infected. Among those who got the updated bivalent ...

In November 2019, a bat coronavirus ... doses of Moderna’s bivalent vaccine, intending to offer both vaccines in the fall and winter. On September 1, 2022, the FDA withdrew its emergency use ...